Cardio-oncology has emerged as a critical subspecialty at the intersection of cancer treatment and cardiovascular medicine, driven by the growing ...
USA: The randomized AVANT GUARD trial has demonstrated that first-line treatment with pulsed field ablation (PFA) ...
All Patients Achieved Meaningful Decreases (Mean = 64%) in Daily Premature Ventricular Contraction Count TN-401 Gene Therapy was Well Tolerated ...
Researchers at Ben-Gurion University of the Negev (BGU) have identified how two different classes of medication—the GLP-1 ...
Short QT syndrome is a genetic disease that leads to sudden cardiac death at a young age. Mutations in the SLC4A3 gene, which ...
For patients with newly diagnosed atrial fibrillation, a quality improvement initiative improved access to specialist care ...
PFA is associated with a significantly lower risk for recurrence of atrial arrhythmia compared with antiarrhythmic-drug therapy receipt.
The portable SGP device emits near-infrared light as a noninvasive autonomic neuromodulation strategy for suppressing ...
Proton-based cardiac radioablation may offer a less invasive treatment for patients with hard-to-treat ventricular tachycardia ...
The likelihood of recurrence of atrial arrhythmia in patients with persistent atrial fibrillation (AFib) was lower for those who received pulsed field ablation (PFA) as first-line therapy when ...
Boston Scientific Corporation (NYSE:BSX) has consistently featured in the 13F portfolio of Farallon Capital since the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results